There are two distinct types of prostate cancer, according to a new AI-driven study published today. The researchers claim that their work may open the door to more personalized therapies for people ...

Prostate cancer is one of the most common cancers in men but often goes unnoticed. Experts stress early screening, awareness ...

Radiosurgery New York (RSNY) Demystifies Kinds of Prostate Cancer for Enhanced Patient Awareness NEW YORK, NY, USA, August 24, 2023/EINPresswire.com/ -- Radiosurgery ...

If you have prostate cancer, your health care provider may have told you about a medicine called Nubeqa (darolutamide). The FDA approved Nubeqa in 2019. It is commonly used to treat prostate cancer ...

A surgeon outlines five important prostate cancer myths that men over 40 should know for early detection and treatment.

Former President Joe Biden was diagnosed with an “aggressive form” of prostate cancer that has a five-year survival rate of between 30% and 40%. The former president’s prostate cancer is characterized ...

Five different recipes of prostate cancer have been identified, with major implications for the way the disease is treated. The "five ways" discovery was made by scientists who studied samples of ...

The probability of survival at 8 years was an unprecedented 78.9% with XTANDI plus leuprolide versus 69.5% with leuprolide, in men with non-metastatic hormone-sensitive prostate cancer with high-risk ...

“The general population’s risk goes up from the age of 50, but if you are one of the men at higher risk of prostate cancer – either because you are a black man, or because you have close relatives who ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.